BioAge Labs BIOA
NASDAQ BIOA
$6.81 -0.28 (-3.95%)
At close: Oct 1, 2026 · 4:00 PM EDT

BioAge Labs (BIOA) Long-Term Investments (2023 - 2026)

Updated

BioAge Labs (BIOA) reported Long-Term Investments of $100,000 for Q2 2026, unchanged from $100,000 a year earlier and unchanged from the prior quarter.

Analysis

BioAge Labs (BIOA) Long-Term Investments (2023 - 2026) Analysis & Trends

Dating back to Q4 2023, BioAge Labs' Long-Term Investments record includes 9 quarters.

  • By year, Long-Term Investments came in at $100,000 in FY2024 (unchanged) and $100,000 in FY2023.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $100,000 (Q1 2026), $100,000 (Q4 2025) and $100,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 266.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.62 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.79 Bn
10 BioAge Labs 324.56 Mn 324.56 Mn -14.23 Mn 100,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 100,000.00
Mar 31, 2026 100,000.00
Dec 31, 2025 100,000.00
Sep 30, 2025 100,000.00
Jun 30, 2025 100,000.00
Mar 31, 2025 100,000.00
Dec 31, 2024 100,000.00
Sep 30, 2024 100,000.00
Dec 31, 2023 100,000.00
API Access

BioAge Labs Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=BIOA&period=max&api_key=YOUR_API_KEY